Rebecca Wenzel

Chicago

Financial Journalist at Mergermarket

Reporter for Mergermarket covering fintech an healthcare. Have a tip or story idea? Tweet me.

Featured in: Favicon

mergermarket.com Favicon

debtwire.com Favicon

info.mergermarket.com

Articles

Partners Group shelves Confluent Health stake sale process - sources

Jan 21, 2025 | ionanalytics.com | Rebecca Wenzel |Deborah Balshem |Dane Hamilton |Carlos Martinez

News (Intelligence) Timing not right for minority recapUnlikely to return to market soonConfluent Health, the Partners Group-backed musculoskeletal health company that was exploring a sale in 2024, ended the process late last year, said three sources familiar with the process.
Concord Technologies taps Baird to explore sale, sources say

Jan 6, 2025 | ionanalytics.com | Dane Hamilton |Rebecca Wenzel |Carlos Martinez

News (Intelligence) Concord Technologies, a healthcare information technology company, has appointed Baird to explore a sale, according to three sources familiar with the situation. Seattle-based Concord, which is minority held by Excellere Partners, generates between USD 40m to USD 50m in EBITDA, two of the sources said. The company recently appointed Baird after a bakeoff and is expected to begin preparations for a sale in the coming months, these sources said.
Centauri Health puts sale process on ice, sources say

Nov 13, 2024 | ionanalytics.com | Rebecca Wenzel |Bhavna Kaul |Dane Hamilton |Carlos Martinez

News (Intelligence) Centauri Health Solutions, a Scottsdale, Arizona-based provider of healthcare software and services, has paused its sale process, according to three sources familiar. The Abry Partners-backed company was pursuing a sale earlier this year alongside William Blair, as reported by Mergermarket.
MB2 pulls sale and pursues Warburg Pincus-funded dividend recap

Nov 5, 2024 | ionanalytics.com | Rebecca Wenzel |Deborah Balshem |Carlos Martinez

News (Intelligence) Proceeds funded distribution to shareholders, doctor partners, and CharlesbankMB2 expects to generate USD 300m EBITDA this yearMB2 Dental, a dental services organization backed by Charlesbank Capital Partners, has pulled its sales process and pursued a dividend recapitalization, according to four sources familiar with the situation.
Fertility services: Sector bankers hoping to deliver more deals - Dealspeak North America

Sep 30, 2024 | ionanalytics.com | Jeff Sheban |Rebecca Wenzel |Izaz Ansari |Deb Balshem

Data Insight Nine months into the year and the prognosis remains strong for dealmaking in the fertility services space, sector bankers say. Several factors are giving the sector new life. People are waiting longer to have children, which increases demand as fertility declines with age. Advances in technology have made in vitro fertilization (IVF) cheaper and more successful, while expanding insurance coverage in more states makes treatment more accessible.
Three Oaks Hospice in market with Harris Williams, sources say

Sep 10, 2024 | ionanalytics.com | Rebecca Wenzel |Deborah Balshem |Carlos Martinez

Three Oaks Hospice, a Dallas-based provider of hospice and palliative care services, is in the midst of a sale process, according to five sources familiar with the matter. The company is working alongside investment bank Harris Williams, according to four of the sources. The process is in the later stages and is down to a few private equity buyers, three of the sources said. Three Oaks generates between USD 12m and USD 15m EBITDA, according to all the sources. The business was founded in May 2019.
The Lactation Network taps Moelis to explore a sale, sources say

Sep 4, 2024 | ionanalytics.com | Rebecca Wenzel |Carlos Martinez

News (Intelligence) The Lactation Network (TLN), a Chicago-based network for insurance-covered lactation services, is exploring a sale alongside Moelis, said two sources familiar with the situation. Privately-held TLN, which generates USD 50m in adjusted EBITDA, is engaging in preliminary conversations with potential suitors, the sources said. A process has not formally launched, they added.
Healthcare technology: R1 RCM deal shines light on revenue cycle sector - Dealspeak North America

Aug 12, 2024 | ionanalytics.com | Jeff Sheban |Rebecca Wenzel |Deborah Balshem |Izaz Ansari

Data Insight Revenue cycle management (RCM) has become one of the brightest stars in the healthcare technology firmament after the USD 7bn bid for R1 RCM [NASDAQ:RCM] from private-equity groups TowerBrook Capital Partners and Clayton, Dubilier & Rice on 1 August.
North American Healthcare Trendspotter: Robust 2H expected after feeble start to year

Jul 10, 2024 | ionanalytics.com | Rebecca Wenzel |Samantha Shaji |Carlos Martinez

The North American healthcare sector saw deal value drop more than 20% to USD USD 112bn from USD 140bn, and the number of deals drop 26% year-over-year to 565 from 768 from 1H23 to 1H24, according to Mergermarket data. Although M&A continues to face macroeconomic headwinds such as inflation, interest rate uncertainty and an impending election, healthcare dealmakers are seeing a strong appetite from buyers, signaling an optimistic outlook for 2H.
Lumeon taps RBC Capital Markets to explore sale, sources say

Jun 4, 2024 | ionanalytics.com | Rebecca Wenzel |Collin Krabbe |Carlos Martinez

News (Intelligence) Lumeon, a Boston-based healthcare technology provider, has hired RBC Capital Markets for a potential sale, according to two sources familiar with the situation. Lumeon is a digital healthcare orchestration platform that helps healthcare providers automate their patient care coordination to improve care quality, outcomes and reduce costs, according to its website.